Hira Abdul Jalil

Dow University of Health Sciences

Papers

1

Total Citations

2

H-Index

1

About

Hira Abdul Jalil is a rising surgical oncologist whose work focuses on advancing minimally invasive techniques for esophageal cancer treatment, particularly in resource-constrained settings. Her key research areas include thoracic oncology, minimally invasive esophagectomy, and improving surgical outcomes in low- and middle-income countries (LMICs). Her most notable contribution is the pioneering "three-staged minimally invasive esophagectomy with end-to-end esophago-gastric anastomosis," a procedure she documented in a 2023 study that demonstrates how complex cancer surgeries can be safely performed in LMICs, addressing a critical gap in global surgical oncology. This work, though early in its citation impact, represents a significant step toward making advanced cancer care more accessible. Dr. Jalil’s research underscores the importance of adapting high-income country protocols to local realities, potentially reducing morbidity and mortality from esophageal cancer—a disease on the rise worldwide. Her dedication to surgical innovation in challenging environments marks her as a promising voice in global health equity and oncologic surgery.

Research Focus

Key Achievements

1
H-Index
1
Papers
2
Total Citations
2
Avg Citations/Paper
🏆 Most Cited Paper
Three-staged minimally invasive esophagectomy with end-to-end esophago-gastric anastomosis for thoracic esophageal cancers: An experience from a low middle-income country
2 citations · 2023
📈 Most Prolific Year: 2023 (1 Papers)
🤝 Key Collaborators: 5
🏛 Institutions: Dow University of Health Sciences

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago